Actos (Pioglitazone)

DRUG3 trials

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of Illinois at Chicago, Taipei Veterans General Hospital, Taiwan

Conditions

DiabetesHepatitisMultiple Sclerosis, Relapsing-Remitting

Phase 1

Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability

CompletedNCT00242177

University of Illinois at ChicagoMultiple Sclerosis, Relapsing-Remitting

Start: 2003-10-31End: 2005-10-31Target: 30Updated: 2019-07-22

Phase 2

Treating Nonalcoholic Steatohepatitis With Pioglitazone

CompletedNCT00062764

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Hepatitis

Start: 2003-06-30End: 2009-02-28Updated: 2012-12-19

Phase 4

Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy

Taipei Veterans General Hospital, TaiwanDiabetes

Start: 2010-07-31End: 2015-12-31Target: 200Updated: 2011-01-05

Related Papers

Renal Outcomes of Pioglitazone Compared with Acarbose in Diabetic Patients: A Randomized Controlled Study

PLoS ONE2016-11-0314 citations